Glucocorticoid does not improve the renal prognosis of patients with diabetic nephropathy combined with acute tubulointerstitial nephritis: a retrospective analysis

References

• Megumi O, Tadashi T, Masakazu H, J.], et al. Estimated glomerular filtration rate decline and risk of end-stage renal disease in type 2 diabetes. PLOS One. 2018;13(8):e0201535. doi: 10.1371/journal.pone.0201535.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega M, Rodrigues-Diez R, Lavoz C, et al. Special issue “diabetic nephropathy: diagnosis, prevention and treatment”. J Clin Med. 2020;9(3):813. doi: 10.3390/jcm9030813.
   PubMed Web of Science ®Google Scholar
• Buse J, Wexler D, Tsapas A, et al. 2019 Update to: management of Hyperglycemia in Type 2 diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2020;43(2):487–493. doi: 10.2337/dci19-0066.
   PubMed Web of Science ®Google Scholar
• Hu Q, Chen Y, Deng X, et al. Diabetic nephropathy: ­focusing on pathological signals, clinical treatment, and dietary regulation. Biomed Pharmacother. 2023;159:114252. doi: 10.1016/j.biopha.2023.114252.
   PubMed Web of Science ®Google Scholar
• Bakris G, Agarwal R, Anker S, et al. Effect of finerenone on chronic kidney disease outcomes in Type 2 diabetes. N Engl J Med. 2020;383(23):2219–2229. doi: 10.1056/NEJMoa2025845.
   PubMed Web of Science ®Google Scholar
• Joyce E, Glasner P, Ranganathan S, et al. Tubulointerstitial nephritis: diagnosis, treatment, and monitoring . Pediatr Nephrol. 2017;32(4):577–587. doi: 10.1007/s00467-016-3394-5.
   PubMed Web of Science ®Google Scholar
• Ruebner R, Fadrowski J. Tubulointerstitial nephritis. Pediatr Clin North Am. 2019;66(1):111–119. doi: 10.1016/j.pcl.2018.08.009.
   PubMed Web of Science ®Google Scholar
• Nakaosa N, Tsuboi N, Okabayashi Y, et al. Tubulointerstitial nephritis: a biopsy case series of 139 Japanese patients . Clin Exp Nephrol. 2022;26(5):435–444. doi: 10.1007/s10157-021-02178-6.
   PubMed Web of Science ®Google Scholar
• Yun D, Jang M, An J, et al. Effect of steroids and relevant cytokine analysis in acute tubulointerstitial nephritis . BMC Nephrol. 2019;20(1):88. doi: 10.1186/s12882-019-1277-2.
   PubMedGoogle Scholar
• Schurder J, Buob D, Perrin P, et al. Acute interstitial ­nephritis: aetiology and management . Nephrol Dial Transplant. 2021;36(10):1799–1802. doi: 10.1093/ndt/gfz262.
   PubMed Web of Science ®Google Scholar
• Caravaca-Fontán F, Fernández-Juárez G, Praga M. Acute kidney injury in interstitial nephritis. Curr Opin Crit Care. 2019;25(6):558–564. doi: 10.1097/MCC.0000000000000654.
   PubMed Web of Science ®Google Scholar
• Huang L, Liang S, Dong J, et al. Prognosis of severe drug-induced acute interstitial nephritis requiring renal replacement therapy. Ren Fail. 2021;43(1):1020–1027. doi: 10.1080/0886022X.2021.1942914.
   PubMed Web of Science ®Google Scholar
• Amaro D, Carreño E, Steeples L, et al. Tubulointerstitial nephritis and uveitis (TINU) syndrome: a review. Br J Ophthalmol. 2020;104(6):742–747. doi: 10.1136/bjophthalmol-2019-314926.
   PubMed Web of Science ®Google Scholar
• Arai H, Ogata S, Ozeki T, et al. Long-term changes in renal function after treatment initiation and the importance of early diagnosis in maintaining renal function among IgG4-related tubulointerstitial nephritis patients in Japan . Arthritis Res Ther. 2020;22(1):261. doi: 10.1186/s13075-020-02320-x.
   PubMed Web of Science ®Google Scholar
• Prendecki M, Tanna A, Salama A, et al. Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids . Clin Kidney J. 2017;10(2):233–239. doi: 10.1093/ckj/sfw116.
   PubMed Web of Science ®Google Scholar
• Fernandez-Juarez G, Perez J, Caravaca-Fontán F, et al. Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis. Clin J Am Soc Nephrol. 2018;13(12):1851–1858. doi: 10.2215/CJN.01390118.
   PubMed Web of Science ®Google Scholar
• Su T, Gu Y, Sun P, et al. Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China. Nephrol Dial Transplant. 2018;33(7):1180–1188. doi: 10.1093/ndt/gfx247.
   PubMed Web of Science ®Google Scholar
• Huang J, Su T, Tan Y, et al. Serum anti-CRP antibodies differentiate etiology and predict relapse in acute tubulointerstitial nephritis. Clin Kidney J. 2022;15(1):51–59. doi: 10.1093/ckj/sfab119.
   PubMed Web of Science ®Google Scholar
• Gérard A, Merino D, Laurain A, et al. Drug-induced tubulointerstitial nephritis: insights from the World Health Organization safety database. Kidney Int Rep. 2022;7(7):1699–1702. doi: 10.1016/j.ekir.2022.04.090.
   PubMed Web of Science ®Google Scholar
• Mose F, Birn H, Hoffmann-Petersen N, et al. Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial. BMC Nephrol. 2021;22(1):161. doi: 10.1186/s12882-021-02372-4.
   PubMed Web of Science ®Google Scholar
• Thomas H, Ford Versypt A. Pathophysiology of ­mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation. J Biol Eng. 2022;16(1):19. doi: 10.1186/s13036-022-00299-4.
   PubMed Web of Science ®Google Scholar
• Bonner R, Albajrami O, Hudspeth J, et al. Diabetic kidney disease . Prim Care. 2020;47(4):645–659. doi: 10.1016/j.pop.2020.08.004.
   PubMed Web of Science ®Google Scholar
• Zheng W, Guo J, Liu Z. Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clin Epigenetics. 2021;13(1):87. doi: 10.1186/s13148-021-01079-5.
   PubMed Web of Science ®Google Scholar
• Arya A, Aggarwal S, Yadav H. Pathogenesis of diabetic nephropathy. Int J Pharm Pharm Sci. 2010;2(4):24–29.
   Google Scholar
• Slyne J, Slattery C, Mcmorrow T, et al. New developments concerning the proximal tubule in diabetic ­nephropathy: in vitro models and mechanisms. Nephrol Dial Transplant. 2015;30 Suppl 4:iv60–iv67. doi: 10.1093/ndt/gfv264.
   PubMed Web of Science ®Google Scholar
• Salti T, Khazim K, Haddad R, et al. Glucose Induces IL-1α-dependent inflammation and extracellular matrix proteins expression and deposition in renal tubular ­epithelial cells in diabetic kidney disease Front Immunol. 2020;11:1270. doi: 10.3389/fimmu.2020.01270.
   PubMed Web of Science ®Google Scholar
• Giancarlo T, Sara C. Tubulointerstitial disease in diabetic nephropathy . Int J Nephrol Renovasc Dis. 2014;7:107–115.
   PubMedGoogle Scholar
• Qu L, Jiao B. The interplay between immune and metabolic pathways in kidney disease . Cells. 2023;12(12):1584. doi: 10.3390/cells12121584.
   PubMed Web of Science ®Google Scholar
• Gonçalves L, Andrade-Silva M, Basso P, et al. Vitamin D and chronic kidney disease: insights on lipid metabolism of tubular epithelial cell and macrophages in tubulointerstitial fibrosis . Front Physiol. 2023;14:1145233. doi: 10.3389/fphys.2023.1145233.
   PubMed Web of Science ®Google Scholar
• Liu B, Zhao L, Yang Q, et al. Hyperuricemia and hypertriglyceridemia indicate tubular atrophy/interstitial fibrosis in patients with IgA nephropathy and membranous nephropathy. Int Urol Nephrol. 2021;53(11):2321–2332. doi: 10.1007/s11255-021-02844-4.
   PubMed Web of Science ®Google Scholar
• Hu Z, Lu J, Chen P, et al. Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic ­nephropathy via the disruption of cholesterol homeostasis. Theranostics. 2020;10(6):2803–2816. doi: 10.7150/thno.40571.
   PubMed Web of Science ®Google Scholar
• Cheng T, Wang X, Han Y, et al. The level of serum albumin is associated with renal prognosis and renal function decline in patients with chronic kidney disease. BMC Nephrol. 2023;24(1):57. doi: 10.1186/s12882-023-03110-8.
   PubMed Web of Science ®Google Scholar
• Song H, Wei C, Hu H, et al. Association of the serum albumin level with prognosis in chronic kidney disease patients. Int Urol Nephrol. 2022;54(9):2421–2431. doi: 10.1007/s11255-022-03140-5.
   PubMed Web of Science ®Google Scholar
• Majoni S, Barzi F, Hoy W, et al. Baseline liver function tests and full blood count indices and their association with progression of chronic kidney disease and renal outcomes in Aboriginal and Torres Strait Islander people: the eGFR follow- up study. BMC Nephrol. 2020;21(1):523. doi: 10.1186/s12882-020-02185-x.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang R, Wang Y, et al. The level of serum albumin is associated with renal prognosis in patients with diabetic nephropathy. J Diabetes Res. 2019;2019:7825804–7825809. doi: 10.1155/2019/7825804.
   PubMed Web of Science ®Google Scholar